While reducing ALK4 expression did not consistently alter activin A- or Nodal-induced Smad2/3 phosphorylation, it significantly enhanced TGF-β1-mediated Smad2/3 phosphorylation in both breast and pancreatic cancer models (Fig. 4a–c). This evidence concerns the gene SMAD2 and pancreatic neoplasm.